Brown Capital Management - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 2 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Brown Capital Management ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2019$411,000
-98.2%
42,117
-98.3%
0.00%
-98.2%
Q3 2019$23,461,000
-45.1%
2,472,229
-31.3%
0.23%
-43.8%
Q2 2019$42,766,000
-33.0%
3,599,792
-0.7%
0.41%
-37.1%
Q1 2019$63,836,000
+0.5%
3,625,010
-0.9%
0.64%
-15.6%
Q4 2018$63,497,000
+16.3%
3,657,665
-0.2%
0.76%
+54.0%
Q3 2018$54,592,000
-6.3%
3,663,9190.0%0.50%
-17.1%
Q2 2018$58,256,000
+2.4%
3,663,919
-8.6%
0.60%
-7.4%
Q1 2018$56,917,000
-12.9%
4,008,239
-14.1%
0.65%
-18.5%
Q4 2017$65,312,000
-16.9%
4,665,143
-15.1%
0.79%
-17.1%
Q3 2017$78,557,000
-11.7%
5,493,466
-2.8%
0.96%
-12.3%
Q2 2017$88,995,000
+13.5%
5,650,457
-0.6%
1.09%
+4.2%
Q1 2017$78,427,000
-22.2%
5,683,095
-0.1%
1.05%
-28.9%
Q4 2016$100,742,000
-8.7%
5,691,631
-0.5%
1.47%
-9.3%
Q3 2016$110,338,000
-1.2%
5,719,938
-0.1%
1.62%
-8.0%
Q2 2016$111,633,000
-5.1%
5,724,776
+0.3%
1.76%
-9.4%
Q1 2016$117,681,000
+4.1%
5,709,876
+3.7%
1.95%
+10.1%
Q4 2015$113,013,000
+21.0%
5,507,476
+0.9%
1.77%
+10.6%
Q3 2015$93,368,000
+12.8%
5,460,129
+23.0%
1.60%
+17.5%
Q2 2015$82,742,000
-2.8%
4,438,971
-0.5%
1.36%
-3.0%
Q1 2015$85,088,000
+15.9%
4,459,5460.0%1.40%
+10.8%
Q4 2014$73,404,000
-8.4%
4,459,546
-1.5%
1.27%
-10.7%
Q3 2014$80,118,000
-18.7%
4,528,986
-5.2%
1.42%
-13.5%
Q2 2014$98,573,000
-2.5%
4,775,800
+2.9%
1.64%
-1.6%
Q1 2014$101,104,000
-18.2%
4,639,914
-0.4%
1.67%
-17.6%
Q4 2013$123,541,000
+22.1%
4,656,648
+8.8%
2.02%
+13.5%
Q3 2013$101,167,000
+10.4%
4,281,114
+0.5%
1.78%
-9.1%
Q2 2013$91,621,0004,261,4511.96%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$340.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MERIDIAN BIOSCIENCE INC shareholders